The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
Clinical trial NCT05062330 · COMPLETED
Trial details
- NCT number
- NCT05062330
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-28
- Primary completion
- 2022-03-04
- Enrollment
- 361
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.